Menu

START Midwest

Grand Rapids, Michigan United States of America

Claim This Site

Are you the site administrator? Claim this site to update information.

1Total Trials
0Recruiting Trials
1Active Trials
0Completed Trials
2Unique Conditions
1Unique Sponsors

Conditions

Advanced Solid Tumor (1)Metastatic Solid Tumor (1)

Sponsors

Artios Pharma Ltd (1)

Affiliations

Basic Information

Site Overview

South Texas Accelerated Research Therapeutics (START) Midwest is a drug development program and clinical trials center based in Grand Rapids, Michigan, established to bring cutting-edge cancer research directly to patients in West Michigan. WWMT It was formed through a partnership between the Cancer and Hematology Centers of Western Michigan (CHCWM) and San Antonio-based START, operating as part of START's global network of Phase I oncology research sites. Crain's Grand Rapids Business START Midwest gives Cancer and Hematology Centers patients first-ever access to experimental treatments and therapies, with Phase I trials led by physicians Dr. Nehal Lakhani, Dr. Manish Sharma, and Dr. Sreenivasa Chandana. CHC A key focus of the program is genomic testing, which identifies gene alterations in a patient's tumor to help guide targeted therapeutic development. WWMT The site is located at 5800 Foremost Drive, Grand Rapids, and is active across numerous cancer types, including…

Business Status

OPEN

Business Category

Cancer treatment center

Business Subcategory

Cancer treatment center
Private hospital
Doctor
Oncologist
Research institute

Accessibility & Parking

Accessibility Features

Wheelchair accessible entrance
Wheelchair accessible parking lot
Wheelchair accessible restroom